Control of microglial neurotoxicity by the fractalkine receptor
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1, S1, and S5) (Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Cardona et al., 2006
In the citing paper
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Cardona et al., 2006
In the citing paper
“Conflicting evidence in the literature suggests either neurotoxic or neuroprotective effects of CX3CR1 deletion in various disease models (Cardona et al., 2006; Fuhrmann et al., 2010).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“Our findings support the concept that fractalkine through its receptor CX3CR1 (Harrison et al., 1998) acts as a repressor of microglia activation (Cardona et al., 2006).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“While CX3CR1 is expressed by many leukocyte cell types in the periphery, 15 in the brain CX3CR1 is exclusively expressed by microglia 13 whereas CX3CL1 is highly expressed within neurons.14”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [13]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“In response to injury, microglial cells undergo rapid morphological and functional activation and acquire properties of mature myeloid cells, including antigen presentation, reactive species generation, matrix metalloproteinase (MMP) expression and phagocytosis, as well as cytokine and growth factor secretio”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“However, peripheral immune and inflammatory reactions are mostly unaltered in Cx3cr1 −/− or Cx3cl1 −/− mic”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Based on these and other findings, efforts to develop pharmacological inhibitors of CX3CR1 are in progres”
BackgroundSelf-citationCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611 · cited 2×
“Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.”
BackgroundSelf-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Results Neuronal damage in Cx3cr1 −/− mice after systemic LPS We first examined the GFP + population in the CNS of Cx3cr1 GFP mice and found that green fluorescent cells overlapped precisely with brain cells expressing microglial markers such as ionized calcium-binding adapter molecule-1 (IBA-1”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“dtd" [ ]> CX3CR1 is expressed by monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells in the circulation and by microglia in the central nervous system (CNS”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 1×
“Knockdown of TREM2 in mouse microglia impairs their phagocytic activity and enhances inflammatory gene expression, suggesting a mechanism for the human disorde”
Background
Cited by
Items 801–900 of 1,003
Lewis, C. B., Solomon, J. N., Rossi, F. M., & Krieger, C. (2009) · Glia · doi:10.1002/glia.20859 · Cited by 40
“Over 100 mutations in the gene encoding the free radical scavenger Cu,Zn- superoxide dismutase (SOD1) have been associated with ALS and mutations in this gene represent roughly 20% of fALS cases (Bruijn et al., 2004).”
BackgroundInfluentialŚlusarczyk, J., Trojan, E., Wydra, K., Głombik, K., Chamera, K., Kucharczyk, M. W., Budziszewska, B., Kubera, M., Lasoń, W., Filip, M., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.008 · Cited by 44
De Felice, E., Gonçalves de Andrade, E., Golia, M. T., González Ibáñez, F., Khakpour, M., Di Castro, M. A., Garofalo, S., Di Pietro, E., Benatti, C., Brunello, N., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02655-z · Cited by 39
“The disruption of CX3CL1–CX3CR1 signaling indeed underlies alteration of circuits development, synaptic maturation, cognitive function, plasticity processes, responses to the environment, and pathogenesis of central nervous system disorders [37, 38, 41, 51, 54, 71, 74, 83].”
BackgroundLi, Y., Li, Y., & Zhu, Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1284214 · Cited by 45
Blomster, L. V., Vukovic, J., Hendrickx, D. A. E., Jung, S., Harvey, A. R., Filgueira, L., & Ruitenberg, M. J. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.08.004 · Cited by 41
Self-citationHuang, L., Xu, W., & Xu, G. (2013) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2013.791925 · Cited by 42
Spinal cord injury drives chronic brain changes
Labombarda, F., & Jure, I. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.211177 · Cited by 45
“Finally, BDNF and other molecules that participate in neuron-glia communication as chemokines (Cardona et al., 2006; Wu et al., 2014b; Gundersen et al., 2015) could be involved in brain changes following SCI.”
Cannabinoid 1 Receptor Signaling on Hippocampal GABAergic Neurons Influences Microglial Activity
Ativie, F., Komorowska‐Müller, J. A., Beins, E. C., Albayram, Ö., Zimmer, T. S., Zimmer, A., Tejera, D., Heneka, M. T., & Bilkei‐Gorzó, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00295 · Cited by 45
“Indeed, reduced expression of CX3CL one is a sign of a diminished control and may be responsible for the pro-inflammatory phenotype of microglia in GABA/CB1 mice (Cardona et al., 2006).”
BackgroundSowa, J. E., & Tokarski, K. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00323-2 · Cited by 41
Xie, W.-L., Shi, Q., Zhang, J., Zhang, B., Gong, H.-S., Guo, Y., Wang, S.-B., Xu, Y., Wang, K., Chen, C., et al. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0002-z · Cited by 42
Thrombin-processed Ecrg4 recruits myeloid cells and induces antitumorigenic inflammation
Lee, J., Dang, X., Borboa, A. K., Coimbra, R. S. M., Baird, A., & Eliceiri, B. P. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou302 · Cited by 45
Self-citationZhang, Y., Zheng, J., Zhou, Z., Zhou, H., Wang, Y., Gong, Z., & Zhu, J. (2015) · FEBS Journal · doi:10.1111/febs.13187 · Cited by 40
Coelho‐Santos, V., Cardoso, F. L., Leitão, R. A., Ribeiro, C., & Silva, A. P. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.016 · Cited by 42
“Afterwards, we investigated the impact of MPH chronic exposure on CX3CR1, a microglia-specific CX3CL1 (Fractalkine) receptor, important in microglia activation (Cardona et al., 2006) and phagocytosis modulation (Zabel et al., 2016).”
InfluentialDexamethasone Induces a Specific Form of Ramified Dysfunctional Microglia
Park, M.-J., Park, H.-S., You, M., Yoo, J., Kim, S. H., & Kwon, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1156-z · Cited by 44
Basic Concept of Microglia Biology and Neuroinflammation in Relation to Psychiatry
Mattei, D., & Notter, T. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_83 · Cited by 39
McDonough, A., Noor, S., Lee, R. V., Dodge, R. E., Strosnider, J. S., Shen, J., Davidson, S., Möller, T., Garden, G. A., & Weinstein, J. R. (2019) · Glia · doi:10.1002/glia.23701 · Cited by 43
“…of CX3CR1-deficiency aremixed: some groups observed aberrant activation of microglia toward a neurotoxic profile in mice lacking CX3CR1 (Cardona et al., 2006; Fumagalli et al., 2013), one study suggests CX3CR1-deficiency is protective against ischemic stroke (Tang et al., 2014), and…”
BackgroundInfluentialSurugiu, R., Cătălin, B., Dumbrava, D., Greșiță, A., Olaru, D. G., Hermann, D. M., & Popa‐Wagner, A. (2019) · Neural Plasticity · doi:10.1155/2019/1071036 · Cited by 42
“Results are presented as Iba-1 and ED-1 cells per 100 μm(2) within areas measured from 40x images using Fiji software (National Institutes of Health) [26].”
MethodSzymura, J., Kubica, J., Więcek, M., & Pera, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010184 · Cited by 43
“One of them is fractalkine, which has been reported to inhibit the release of inflammatory cytokines while reducing microglia activation [8].”
BackgroundEfferocytosis in multisystem diseases (Review)
Zhang, Y., Wang, Y., Ding, J., & Liu, P. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12529 · Cited by 47
Setayesh, S., & Rahimi, G. R. M. (2023) · Geriatric Nursing · doi:10.1016/j.gerinurse.2023.08.022 · Cited by 55
Rodriguez, D., Church, K. A., Pietramale, A. N., Cardona, S. M., Vanegas, D., Rorex, C., Leary, M. C., Muzzio, I. A., Nash, K. R., & Cardona, A. E. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02983-8 · Cited by 40
“The study described here complements our previous work, showing that disruption of CX3CR1/FKN signaling correlated with altered microglia morphology, perivascular clustering, and proliferation, resulting in augmented loss of retinal neurons [2–4, 30, 31].”
ResultSelf-citationPatrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity
Bellavance, M.-A., Gosselin, D., Yong, W. V. R., Stys, P., & Rivest, S. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0759-z · Cited by 41
“In the CNS, Cx3cr1 is exclusively expressed by microglia and perivascular macrophages whereas its sole known ligand, fractalkine (CX3CL1), is constitutively expressed by healthy neurons (Cardona et al. 2006).”
BackgroundInfluentialEffects of neferine on CCL5 and CCR5 expression in SCG of type 2 diabetic rats
Li, G., Xu, H., Zhu, S., Xu, W., Qin, S.-L., Liu, S., Tu, G., Peng, H., Qiu, S., Yu, S., et al. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.10.002 · Cited by 37
Synaptic Failure: Focus in an Integrative View of ALS
Casas, C., Manzano, R., Vaz, A. R., Osta, R., & Brites, D. M. T. O. (2015) · Brain Plasticity · doi:10.3233/bpl-140001 · Cited by 42
“Neuroprotective signaling from MN to microglia can be mediated through at least two cytokines, the chemokine ligand 1 (CX3CL1/fractalkine) and the membrane glycoprotein CD200 that have the correspondent receptors CX3CR1 and C200R, respectively, restricted to microglia [86, 87].”
BackgroundA Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders
|lusarczyk, J., Trojan, E., Chwastek, J., G|ombik, K., & Basta-Kaim, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160219131357 · Cited by 37
“Cardona and collaborators [120] demonstrated that in many models of neurodegenerative disorders, the loss of neuron-microglia interactions by disturbances in the fractalkine and its receptor signaling resulted in microglial activation and, consequently, in worsening of the disease.”
Lana, D., Ugolini, F., Nosi, D., Wenk, G. L., & Giovannini, M. G. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00296 · Cited by 40
“(2016), although CX3CL1 is considered to be principally expressed by neurons, while its receptor by microglia (Harrison et al., 1998; Cardona et al., 2006; Lauro et al., 2008), it is still debatable whether other cell types also express CX3CL1.”
BackgroundBarati, S., Kashani, I. R., Moradi, F., Tahmasebi, F., Mehrabi, S., Barati, M., & Joghataei, M. T. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28670 · Cited by 40
“The CX3CR1 is like a receptor on microglia and CX3CL1 is produced by neuron and MSCs.40,41 Uccelli et al42 have reported that CX3CR1/ CX3CL1 axis could modulate microglial/ neuron interaction and neuronal supporting against toxic factors.”
BackgroundInfluentialGellner, A., Reis, J., Fiebich, B. L., & Fritsch, B. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.08.007 · Cited by 42
“Due to its exclusive 9 expression of the fractalkine receptor CX3CR1, microglia is equipped for neuron-glial 10 communication via this particular neuronal chemokine (CX3CL1, [21,34]).”
BackgroundSong, C., Honmou, O., Furuoka, H., & Horiuchi, M. (2011) · Journal of Virology · doi:10.1128/jvi.05318-11 · Cited by 42
“The stimulation of CX3CR1 by its ligand CX3CL1 plays a role in modulating the release of proinflammatory cytokines from microglia (7, 21) and in producing neuroprotective substances (31).”
BackgroundWIN55,212-2 Inhibits Production of CX3CL1 by Human Astrocytes: Involvement of p38 MAP Kinase
Sheng, W. S., Hu, S., Ni, H. T., Rock, R. B., & Peterson, P. K. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9147-5 · Cited by 36
“It is reasonable to postulate that multiple factors in the local environment, e.g., cytokines/chemokines as well as blood–brain barrier integrity (Cardona et al. 2006), may determine whether CX3CL1-CX3CR1 interactions have deleterious or beneficial consequences in the brain.”
Therapeutic targeting of chemokine signaling in Multiple Sclerosis
Hamann, I., Zipp, F., & Infante‐Duarte, C. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.07.005 · Cited by 38
“CX3CR1 CX3CL1 • Constitutive expression of receptor and ligand in brain [95-97] • Increased level of ligand in CSF of patients with neuroinflammation, but only in MS patients increased levels of ligand in sera [98]”
Central Nervous System: (Immunological) Ivory Tower or Not?
Marin, I. A., & Kipnis, J. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.122 · Cited by 39
“Although the microglia in these mice reach normal numbers in adulthood, they appear to have an exuberant production of inflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNFα) (Cardona et al, 2006; Cho et al, 2011; Dudley et al, 2002).”
BackgroundLópez-López, A., Gelpí, E., Lopategui, D. M., & Vidal-Taboada, J. M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0489-3 · Cited by 35
“endogenous neuronal modulator that may limit microglial activity in AD [27, 28] by reducing the inflammatory reaction through fractalkine/NRF2/heme oxygenase 1 pathway [29].”
BackgroundIto, N., Hirose, E., Ishida, T., Hori, A., Nagai, T., Kobayashi, Y., Kiyohara, H., Oikawa, T., Hanawa, T., & Odaguchi, H. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0876-8 · Cited by 43
The Multiple Roles of Pericytes in Vascular Formation and Microglial Functions in the Brain
Hattori, Y. (2022) · Life · doi:10.3390/life12111835 · Cited by 42
Chemokine receptors as important regulators of pathogenesis during arboviral encephalitis
Michlmayr, D., & Lim, J. K. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00264 · Cited by 41
“Hosking, M. P., and Lane, T. E. (2010). The role of chemokines during”
BackgroundInfluentialLiebscher, S., & Meyer-Luehmann, M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00026 · Cited by 36
Complex role of chemokine mediators in animal models of Alzheimer's Disease
Martin, E., & Delarasse, C. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.01.002 · Cited by 42
“[18] Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, et al.”
BackgroundInfluentialDysfunctional microglia and tau pathology in Alzheimer’s disease
Ayyubova, G. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0087 · Cited by 35
CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer’s Disease
Bivona, G., Iemmolo, M., & Ghersi, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098230 · Cited by 35
“However, considering the controversy around the presence of CX3CR1 on neurons, with some authors [35,57,58] reporting selective microglial expression of the receptor, Dworzak’s findings should be interpreted with caution.”
BackgroundHigh‐resolution in vivo imaging of microglia using a versatile nongenetically encoded marker
Schwendele, B., Brawek, B., Hermes, M., & Garaschuk, O. (2012) · European Journal of Immunology · doi:10.1002/eji.201242436 · Cited by 35
Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice
Gómez‐Nicola, D., Spagnolo, A., Guaza, C., & Nieto‐Sampedro, M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.034 · Cited by 41
“On the contrary, studies in vivo demonstrated that CX3CR1 deficiency caused altered microglial responses that resulted in neurotoxicity (Cardona et al., 2006).”
Desforges, N. M., Hebron, M., Algarzae, N. K., Lonskaya, I., & Moussa, C. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/345472 · Cited by 43
“CX3CR1 knockout mice show more toxicity and substantia nigra (SN) degeneration in response to LPS treatment following administration of 1methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a neurotoxic precursor of 1-methyl-4-phenylpyridinium (MPP+) [57].”
BackgroundInfluentialHIV-1 Tat Disrupts CX3CL1-CX3CR1 Axis in Microglia via the NF-κBYY1 Pathway
Duan, M., Yao, H., Cai, Y. C., Liao, K., Seth, P., & Buch, S. J. (2014) · Current HIV Research · doi:10.2174/1570162x12666140526123119 · Cited by 36
“In fact, in three different clinically relevant in vivo models including systemic inflammation (LPS), MPTP model of Parkinson’s disease and a model of ALS, CX3CR1 deficiency has been shown to play a key role in microglial neurotoxicity [12].”
Briones, T. L., Woods, J., & Wadowska, M. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-13 · Cited by 36
“Using this animal model, studies on lateral amyotrophic sclerosis [12], Parkinson’s disease [13], and Alzheimer’s disease [14] report that the absence of CX3CR1 is associated with a worse outcome possibly due to the lack of fractalkine control of microglial activation leading to chronic proinflammatory function [15].”
ResultRetractedBatsaikhan, B., Wang, J.-Y., Scerba, M. T., Tweedie, D., Greig, N. H., Miller, J. P., Hoffer, B. J., Lin, C.-T., & Wang, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030502 · Cited by 36
“This method of detecting early apoptotic cells has been widely used for in vitro and in vivo imaging of apoptosis [32,33].”
Emerging roles for hypothalamic microglia as regulators of physiological homeostasis
Rosin, J. M., & Kurrasch, D. M. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100748 · Cited by 40
Role of chemokines in Parkinson's disease
Liu, J., Chu, S., Zhou, X., Zhang, D., & Chen, N. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.05.020 · Cited by 39
Antunes, M. S., Ruff, J. R., Janner, D. E., Piêgas, M. B., de Brito, M. L. O., Rocha, K. M. A., de Gomes, M. G., Goes, A. T. R., Souza, L. C., Donato, F., et al. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.05.018 · Cited by 34
Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype
Lane, R. M., & He, Y. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.005 · Cited by 39
“[157] Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, et al.”
BackgroundGlial cross-talk by transmembrane chemokines CX3CL1 and CXCL16
Ludwig, A., & Mentlein, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.024 · Cited by 36
“CX3CR1-deficient mice have been studied in models of CNS response to systemic inflammation, Parkinson disease, and amylotrophic lateral sclerosis (ALS), and expression of CX3CR1 seems to be beneficial for neuroprotection and survival (Cardona et al., 2006).”
BackgroundLoss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma
Breen, K., Anderson, S., Steele, M. R., Calkins, D. J., Bosco, A., & Vetter, M. L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00526 · Cited by 39
“However, while we found that Nos2 was upregulated, as discussed above, we did not observe a significant increase in Il1β with loss of Cx3cr1 in the DBA/2J retina or in sorted myeloid cells including microglia.”
InfluentialCNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model
Finneran, D. J., Morgan, D., Gordon, M. N., & Nash, K. R. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9822-5 · Cited by 34
The Fine Balance of Chemokines During Disease: Trafficking, Inflammation, and Homeostasis
Cardona, S. M., Garcia, J. A., & Cardona, A. E. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-426-5_1 · Cited by 37
“Microglial activation also plays an important role in the pathology of MS and CX3CR1 was shown to inhibit microglial activation and neurotoxicity (23).”
BackgroundSelf-citationNeuroimmune Biomarkers in Mental Illness
Herron, J. W., Nerurkar, L., & Cavanagh, J. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_45 · Cited by 37
Dou, F., Chu, X., Zhang, B., Liang, L., Lü, G., Ding, J., & Chen, S. (2018) · Molecular Brain · doi:10.1186/s13041-018-0418-z · Cited by 34
Gutiérrez, I. L., González‐Prieto, M., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01695-6 · Cited by 37
Guo, X., Rao, Y., Mao, R., Cui, L., & Fang, Y. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108336 · Cited by 38
Sarma, J. D., Burrows, A. C., Rayman, P. A., Hwang, M., Kundu, S., Sharma, N., Bergmann, C. C., & Sen, G. C. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009034 · Cited by 35
“Ifit2 deficiency does not affect the expression of selected proinflammatory cytokines and chemokines in the infected brains at mRNA levels Neurotropic MHV infection in WT mice induces a variety of chemokines and cytokines, which not only promote innate immune responses in resident cells, but also regulate BBB integrit…”
BackgroundInfluentialZhao, J., Chen, M., & Xu, H. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15495 · Cited by 37
Identifying molecular mediators of environmentally enhanced neurogenesis
Eisinger, B. E., & Zhao, X. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2718-5 · Cited by 43
“For example, the chemokine CX3CL1 (also known as fractalkine or neurotactin) promotes a preponderance of neuroprotective microglia over pro-inflammatory microglia (Cardona et al. 2006).”
Yan, B. C., Xu, P., Gao, M., Wang, J., Jiang, D., Zhu, X., Won, M., & Su, P. Q. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00775 · Cited by 36
“Excessive microglial activation may also contribute to the pathophysiological process of epilepsy (64, 65) because pathophysiological changes in the brain that are induced by activated microglia, such as inflammation, can compromise barrier function and kill neurons in the BBB (66).”
BackgroundHow Many Cell Types Does It Take to Wire a Brain?
Ransohoff, R. M., & Stevens, B. (2011) · Science · doi:10.1126/science.1212112 · Cited by 34
Self-citationErnest James Phillips, T., & Maguire, E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.652593 · Cited by 33
Anomalies in neurovascular coupling during early diabetes: A review
Fletcher, E. L., Dixon, M., Mills, S. A., & Jobling, A. I. (2022) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14190 · Cited by 39
“68–70 Fractalkine, which is expressed by neurons, is an important regulator of microglial activation and is thought to play a role in dampening neurotoxicity in the brain and retina.(62,71,72) Fractalkine expression is increased in diabetic Ins2 mice compared to control and that subsequent genetic ablation of Cx3cr1 i…”
BackgroundThe Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases
Iemmolo, M., Ghersi, G., & Bivona, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098026 · Cited by 36
“Furthermore, because microglia react quickly to protect normal neurons and eliminate damaged neurons in the brain, microglia can act as a sentinel for neurons [31].”
BackgroundMurai, N., Mitalipova, M., & Jaenisch, R. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14879 · Cited by 33
“In the brain, the expression of CX3CR1 is microglia-specific (Cardona et al., 2006) and the expression of its ligand CX3CL1 is neuron-specific (Harrison et al.”
BackgroundPetralla, S., Chirico, F. D., Miti, A., Tartagni, O., Massenzio, F., Poeta, E., Virgili, M., Zuccheri, G., & Monti, B. (2021) · Biomolecules · doi:10.3390/biom11020306 · Cited by 39
“In the genetic ALS model (G93ASOD1) of spinal cord motoneuronal death, CX3CR1 deficiency was accompanied by higher levels of microglia activation and by the parallel increased neuronal death, compared to wild-type mice, where the neurotoxic activity of microglial cells was prevented by the CX3CL1–CX3CR1 axis [34].”
BackgroundThe microglia-blood vessel interactions in the developing brain
Hattori, Y. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.09.006 · Cited by 38
Microglia sequelae: brain signature of innate immunity in schizophrenia
Rodrigues‐Neves, A. C., Ambrósio, A. F., & Gomes, C. A. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02197-1 · Cited by 36
Ni, J., Xie, Z., Quan, Z., Meng, J., & Qing, H. (2023) · Glia · doi:10.1002/glia.24465 · Cited by 34
“In a model of retinitis pigmentosa, CX3CR1-deficient microglia showed increased phagocytosis, as evidenced by an increase in the number of phagosomes in vivo, the rate of phagocytosis of fluorescent beads and photoreceptor cellular debris in vitro, and photoreceptor phagocytosis dynamics during live cell imaging (Zabe…”
BackgroundInfluentialChen, M., Luo, C., Penalva, R., & Xu, H. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10888 · Cited by 33
Mitophagy-associated programmed neuronal death and neuroinflammation
Zhu, Y., Zhang, J., Deng, Q., & Chen, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1460286 · Cited by 40
Unravelling the glial response in the pathogenesis of Alzheimer's disease
Alibhai, J. D., Diack, A. B., & Manson, J. C. (2018) · The FASEB Journal · doi:10.1096/fj.201801360r · Cited by 31
Aberrantly expressed long noncoding RNAs and genes in Parkinson's disease
Zhou, Y., Cheng-zhi, G., Li, J., Zhu, L., Huang, G., Dai, J., & Huaiyu, H. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s178435 · Cited by 32
“Knockout of CX3CR1 was found to exacerbate inflammation and neurodegeneration in a 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine neurotoxin model of PD.(23) Sun et al demonstrated for the first time that CX3CR1 is involved in the neuroinflammatory process in 1-methyl-4phenylpyridiniumion (MPP+) rat model of PD.”
BackgroundGumbs, S. B. H., Kübler, R., Gharu, L., Schipper, P., Borst, A., Snijders, G., Ormel, P., van Berlekom, A. B., Wensing, A., de Witte, L., et al. (2022) · Journal of Neurovirology · doi:10.1007/s13365-021-01049-w · Cited by 29
“In this regard, another attempt to drive these cells closer to a microglia fate has been by optimizing the culture media composition with the addition of cytokines (TGF-β, CX3CL1, and CD200) critical for maintaining microglial homeostasis (Abud et al. 2017; Butovsky et al. 2014; Cardona et al. 2006; Hoek et al. 2000;…”
BackgroundDagkalis, A., Wallace, C., Hing, B., Liversidge, J., & Crane, I. J. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03046.x · Cited by 32
Interglial Crosstalk in Obesity-Induced Hypothalamic Inflammation
Rahman, M. H., Kim, M.-S., Lee, I., Yu, R., & Suk, K. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00939 · Cited by 43
“Fractalkine and its receptor play a pivotal role in the recruitment, infiltration, and proinflammatory polarization of leukocytes and microglial cells that are involved in the regulation of neuroinflammatory conditions (Cardona et al., 2006; Cardona et al., 2008), indicating that the chemokine acts as a mediator in th…”
BackgroundCX3CL1/CX3CR1 signal mediates M1-type microglia and accelerates high-altitude-induced forgetting
Wang, X., Xie, Y., Niu, Y., Wan, B., Lu, Y., Luo, Q., & Zhu, L. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1189348 · Cited by 40
“Adult CX3CR1 deficient mice showed increased autonomic neurotoxicity (Cardona et al., 2006; Reemst et al., 2016).”
BackgroundPraet, J., Orije, J. E. M. J., Kara, F., Guglielmetti, C., Santermans, E., Daans, J., Hens, N., Verhoye, M., Berneman, Z. N., Ponsaerts, P., et al. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3277 · Cited by 35
“CX3CL1/CX3CR1 signaling has previously been identified as a major regulator of microglial activity (19,20).”
BackgroundBlon, D. L., Hoornaert, C., Daans, J., Santermans, E., Hens, N., Goossens, H., Berneman, Z. N., & Ponsaerts, P. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.49 · Cited by 34
Zhou, Y., Sheets, K. G., Knott, E. J., Regan, C. E., Tuo, J., Chan, C., Gordon, W. C., & Bazan, N. G. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.07.017 · Cited by 32
“CX3CR1 signaling alters retinal microglia dynamics (Liang et al., 2009) and regulates microglial neurotoxicity (Cardona et al., 2006).”
BackgroundChen, P., Hsiao, C., Chiang, S.-J., Shen, R.-S., Lin, Y., Chung, K., & Tsai, S. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674211062532 · Cited by 31
“Both trans-membrane and soluble form CX3CL1 bind to receptor CX3CR1 in microglia and mediates the bidirectional cross-talk between neurons and microglia in the pathological brains (Biber et al., 2007; Cardona et al., 2006; Hughes et al., 2003; Poniatowski et al., 2017).”
BackgroundBoivin, N., Menasria, R., Gosselin, D., Rivest, S., & Boivin, G. (2012) · Journal of General Virology · doi:10.1099/vir.0.041046-0 · Cited by 38
PPAR‐γ, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches
Malchiodi‐Albedi, F., Matteucci, A., Bernardo, A., & Minghetti, L. (2008) · PPAR Research · doi:10.1155/2008/295784 · Cited by 35
“In transgenic mice lacking CX3CR1, microglia migrate defectively and accumulate in the subretinal space, evoking morphological and pathological features similar to those observed in human AMD.”
BackgroundProliferating culture of aged microglia for the study of neurodegenerative diseases
Rommy von Bernhardi, M., Tichauer, J. E., & Bernhardi, L. E.-V. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.08.027 · Cited by 34
“It is known that ex vivo isolated microglia from adult animals (Cardona et al., 2006) undergo extensive cell death (Tomozawa et al.”
BackgroundBeckers, L., Geric, I., Stroobants, S., Beel, S., Van Damme, P., D’Hooge, R., & Baes, M. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1442-3 · Cited by 30
Will Stem Cell Biology Generate New Therapies for Parkinson's Disease?
McKay, R. D. G., & Kittappa, R. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.016 · Cited by 32
“Fractalkine is a chemokine (CX3CL1) that protects motor neurons from the damaging effects of the SOD1G93A mutation by inhibiting inflammatory responses (Cardona et al., 2006).”
BackgroundCaspases orchestrate microglia instrumental functions
Shen, X., Venero, J. L., Joseph, B., & Burguillos, M. Á. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.09.007 · Cited by 32
Aurelian, L., & Balan, I. S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05220-4 · Cited by 37
Dopaminergic Pathways in Obesity-Associated Inflammation
Leite, F., & Ribeiro, L. V. P. T. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09863-0 · Cited by 34
“Brain macrophages, the microglia, establish a bidirectional communication with neurons in both physiological and pathological states (Schafer et al. 2012; Cardona et al. 2006; Wohleb 2016; Szepesi et al. 2018).”
BackgroundSanchez-Molina, P., Almolda, B., Giménez‐Llort, L., González, B., & Castellano, B. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.12.026 · Cited by 35
Microglial carbohydrate-binding receptors for neural repair
Linnartz‐Gerlach, B., Bodea, L., & Neumann, H. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1342-7 · Cited by 32
Lou, Z., Zhao, C., & Xiao, B. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22721 · Cited by 33
“Although CX3CL1 is widely expressed throughout the CNS of rodents and humans (Cardona et al., 2006), its physiological role is still largely unexplored.”
BackgroundTargeting CB2 receptor as a neuroinflammatory modulator in experimental autoimmune encephalomyelitis
Lou, Z., Chen, C., He, Q., Zhao, C., & Xiao, B. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.09.016 · Cited by 35
“Although CX3CL1 is widely expressed throughout the NS of rodents and human (Cardona et al., 2006), its physiological ole is still largely unexplored.”
BackgroundOverstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration
Chen, J., Connor, K. M., & Smith, L. E. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33513 · Cited by 29
Tichauer, J. E., Arellano, G., Acuña, E., González, L. F., Kannaiyan, N. R., Murgas, P., Panadero-Medianero, C., Ibañez-Vega, J., Burgos, P. I., Loda, E., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1191838 · Cited by 35
“MG are characterized by a prominent expression of the fractalkine receptor CX3CR1, which is not expressed in astrocytes, oligodendrocytes, or neurons (7, 8).”
BackgroundImmunology of amyotrophic lateral sclerosis – role of the innate and adaptive immunity
Mimic, S., Aru, B., Pehlivanoğlu, C., Sleiman, H., Anđjus, P. R., & Demirel, G. Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1277399 · Cited by 32
“Additionally, microglial cells can produce reactive oxygen species (Cardona et al., 2006).”
BackgroundMosley, R. L., & Gendelman, H. E. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.018 · Cited by 30
“In PD and ALS models Cx3cr1−/− mice showed more extensive neuronal cell loss than Cx3cr1 littermate controls (Cardona et al., 2006).”
BackgroundMicroglial Cx3cr1knockout reduces prion disease incubation time in mice
Grizenkova, J., Akhtar, S., Brandner, S., Collinge, J., & Lloyd, S. E. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-44 · Cited by 29
“accelerated deterioration of hind limb grip function and reduced survival were also seen [9].”
Background
Metadata
- Authors
- Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- National Institute of Environmental Health Sciences (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ransohoff, Richard M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 917-924
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2113107925
- Cited by
- 1,531
- References
- 39
- Citations by year
- 2026: 46 · 2025: 44 · 2024: 84 · 2023: 62 · 2022: 83 · 2021: 73 · 2020: 66 · 2019: 76 · 2018: 95 · 2017: 90 · 2016: 87 · 2015: 102 · 2014: 133 · 2013: 104 · 2012: 90
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS32151, R01NS032151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, CX3CR1, microglial neurotoxicity, neuroinflammation, lipopolysaccharide, Parkinson's disease, amyotrophic lateral sclerosis, neuronal loss, CX3CR1 knockout mice
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Calcium-Binding Proteins, Cells, Cultured, Central Nervous System, Disease Models, Animal, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Neurons, Parkinson Disease, Cytokines, Motor Neuron Disease, Cell Death, Microglia, Receptors, Chemokine, Neurotoxicity Syndromes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.